Journal
AMERICAN JOURNAL OF ROENTGENOLOGY
Volume 199, Issue 2, Pages 458-464Publisher
AMER ROENTGEN RAY SOC
DOI: 10.2214/AJR.10.6096
Keywords
breast cancer; breast ultrasound; estrogen receptor (ER); human epidermal growth factor receptor 2 (HER2); mammography; progesterone receptor (PR); triple receptor-negative breast cancer
Funding
- National Institutes of Health [UL1RR024986]
Ask authors/readers for more resources
OBJECTIVE. The objective of our study was to retrospectively evaluate the imaging findings of patients with breast cancer negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)-so-called triple receptor-negative cancer-and to compare the mammographic findings and clinical characteristics of triple receptor-negative cancer with non-triple receptor-negative cancers (i.e., ER-positive, PR-positive, or HER2-positive or two of the three markers positive). CONCLUSION. Triple receptor-negative cancer was most commonly an irregular noncalcified mass with ill-defined or spiculated margins on mammography and a hypoechoic or complex mass with an irregular shape and noncircumscribed margins on ultrasound. Most triple receptor-negative cancers were discovered on physical examination. Compared with non-triple receptor-negative cancers, triple receptor-negative cancers were found in younger women and were a higher pathologic grade.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available